GlassScriptPhysician profile
Jonathan James Creech
NPI 1386166395
$2,891.14
in general payments reported to CMS, 2019-2025
19 companies · $521 in 2025
The $521 reported for 2025 was more than what 78% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $473 · 2020: $42.28 · 2021: $489 · 2022: $607 · 2023: $316 · 2024: $442 · 2025: $521.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,264 · Entertainment: $15.15.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,264.26 |
| Entertainment | $15.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $928.85 | 2020-2025 | Tryptyr, Precision 1, Dailies Total1 |
| Coopervision INC. | $497.66 | 2019-2025 | Myday Contact Lens, Clariti Contact Lens |
| Tarsus Pharmaceuticals, INC. | $210.55 | 2024-2025 | Xdemvy |
| Allergan, INC. | $161.98 | 2021-2022 | |
| Aerie Pharmaceuticals, INC. | $126.19 | 2019 | |
| Dompe US, INC. | $125.00 | 2021 | |
| Abbvie INC. | $123.73 | 2022-2023 | Vuity, Lumigan |
| Glaukos Corporation | $122.94 | 2021-2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $119.29 | 2019 | |
| Optos, INC. | $107.74 | 2022-2025 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Maculogix, INC. | $81.99 | 2019 | |
| Lombart Brothers, INC. | $60.39 | 2025 | Opd-III |
| Lkc Technologies, INC. | $58.40 | 2024 | |
| Kala Pharmaceuticals, INC. | $40.88 | 2022 | |
| Harrow Eye, LLC | $37.23 | 2025 | Vevye |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rxsight INC | $31.78 | 2025 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge |
| Tearlab Corp | $22.68 | 2021 | |
| Novartis Pharmaceuticals Corporation | $18.24 | 2022 | |
| Oyster Point Pharma, INC. | $15.62 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Creech listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.